H. Campbell, I. Rudan, A. Bittles, and A. Wright, Human population structure, genome autozygosity and human health, Genome Medicine, vol.1, issue.9, pp.91-101, 2009.
DOI : 10.1186/gm91

D. Curtis, A. Vine, and J. Knight, Study of Regions of Extended Homozygosity Provides a Powerful Method to Explore Haplotype Structure of Human Populations, Annals of Human Genetics, vol.73, issue.5, pp.261-78, 2008.
DOI : 10.1111/j.1469-1809.2007.00411.x

S. Wang, C. Haynes, F. Barany, and J. Ott, Genome-wide autozygosity mapping in human populations, Genetic Epidemiology, vol.56, issue.2, pp.172-80, 2009.
DOI : 10.1186/1479-7364-1-4-287

W. Wiszniewski, M. Fondaneche, N. Lambert, K. Masternak, C. Picard et al., Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group B, Immunogenetics, vol.51, issue.4-5, pp.4-5261, 2000.
DOI : 10.1007/s002510050619

H. Naamane, E. Maataoui, O. Ailal, F. Barakat, A. Bennani et al., The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population, European Journal of Pediatrics, vol.54, issue.5, pp.1069-74, 2010.
DOI : 10.1016/0092-8674(93)90685-J

W. Al-herz, H. Aldhekri, M. Barbouche, and N. Rezaei, Consanguinity and Primary Immunodeficiencies, Human Heredity, vol.77, issue.1-4, pp.138-181, 2014.
DOI : 10.1159/000357710
URL : https://hal.archives-ouvertes.fr/pasteur-01375102

C. Picard, W. Herz, A. Bousfiha, J. Casanova, T. Chatila et al., Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015, Journal of Clinical Immunology, vol.35, issue.8, pp.696-726, 2015.
DOI : 10.1007/s10875-015-0201-1

H. Al-mousa, M. Abouelhoda, D. Monies, N. Al-tassan, A. Ghonaium et al., Unbiased targeted next-generation sequencing molecular approach for primary immunodeficiency diseases, Journal of Allergy and Clinical Immunology, vol.137, issue.6, pp.1780-1787, 2016.
DOI : 10.1016/j.jaci.2015.12.1310

B. Gathmann, N. Binder, S. Ehl, G. Kindle, . Esid-registry-working et al., The European internet-based patient and research database for primary immunodeficiencies: update 2011, Clinical & Experimental Immunology, vol.118, issue.1, pp.479-91, 2012.
DOI : 10.1182/blood-2011-04-347641

B. Al-saud, H. Mousa, A. Gazlan, S. Ghonaium, A. Arnaout et al., Primary immunodeficiency diseases in Saudi Arabia: a tertiary care hospital experience over a period of three years, 2010.

N. Galal, S. Meshaal, R. Elhawary, D. Elaziz, R. Alkady et al., Patterns of Primary Immunodeficiency Disorders Among a Highly Consanguineous Population: Cairo University Pediatric Hospital???s 5-Year Experience, Journal of Clinical Immunology, vol.185, issue.1, pp.649-55, 2016.
DOI : 10.1086/340510

M. Ouederni, Q. Vincent, P. Frange, F. Touzot, S. Scerra et al., Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients, Blood, vol.118, issue.19, pp.5108-5126, 2011.
DOI : 10.1182/blood-2011-05-352716

M. Barbouche, N. Galal, I. Ben-mustapha, L. Jeddane, F. Mellouli et al., Primary immunodeficiencies in highly consanguineous North African populations, Annals of the New York Academy of Sciences, vol.89, issue.Suppl. 1, pp.42-52, 2011.
DOI : 10.1097/MD.0b013e3181fdd832
URL : https://hal.archives-ouvertes.fr/pasteur-00658358

N. Rezaei, A. Aghamohammadi, M. Moin, Z. Pourpak, M. Movahedi et al., Frequency and Clinical Manifestations of Patients with Primary Immunodeficiency Disorders in Iran: Update from the Iranian Primary Immunodeficiency Registry, Journal of Clinical Immunology, vol.134, issue.6, pp.519-551, 2006.
DOI : 10.1016/S0891-5245(02)25178-0

W. Al-herz, Primary Immunodeficiency Disorders in Kuwait: First Report from Kuwait National Primary Immunodeficiency Registry (2004???2006), Journal of Clinical Immunology, vol.361, issue.6, pp.186-93, 2004.
DOI : 10.1016/S0301-0546(01)79031-3

S. Reda, H. Afifi, and M. Amine, Primary Immunodeficiency Diseases in Egyptian Children: A Single-Center Study, Journal of Clinical Immunology, vol.147, issue.2, pp.343-51, 2009.
DOI : 10.1111/j.1365-2249.2006.03292.x

L. Tanugi-cholley, J. Issartel, J. Lunardi, F. Freycon, F. Morel et al., A mutation located at the 5' splice junction sequence of intron 3 in the p67phox gene causes the lack of p67phox mRNA in a patient with chronic granulomatous disease, Blood, vol.85, issue.1, pp.242-251, 1995.

E. Jouanguy, F. Altare, S. Lamhamedi, P. Revy, J. Emile et al., Interferon-?? ???Receptor Deficiency in an Infant with Fatal Bacille Calmette???Gu??rin Infection, New England Journal of Medicine, vol.335, issue.26, pp.1956-6110, 1056.
DOI : 10.1056/NEJM199612263352604

C. Fiorini, S. Jilani, C. Losi, A. Silini, S. Giliani et al., A novel activation-induced cytidine deaminase gene mutation in a Tunisian family with hyper IgM syndrome, European Journal of Pediatrics, vol.50, issue.12, pp.704-712, 2004.
DOI : 10.1007/s00431-004-1540-8

H. Ouadani, I. Ben-mustapha, M. Ben-ali, L. Ben-khemis, B. Largueche et al., Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients, Immunogenetics, vol.50, issue.1, pp.19-28, 2016.
DOI : 10.1006/clim.2001.5022
URL : https://hal.archives-ouvertes.fr/hal-01356502

N. Mekki, I. Ben-mustapha, L. Liu, L. Boussofara, S. Okada et al., IL-17 T Cells??? Defective Differentiation In Vitro Despite Normal Range Ex Vivo in Chronic Mucocutaneous Candidiasis Due to STAT1 Mutation, Journal of Investigative Dermatology, vol.134, issue.4, pp.1155-1162, 2014.
DOI : 10.1038/jid.2013.480
URL : https://hal.archives-ouvertes.fr/pasteur-01061212

M. Ben-ali, Y. J. Chan, K. Ben-mustapha, I. Mekki, N. Benabdesselem et al., Homozygous TCF3 mutation is associated with severe hypogammaglobulinemia and B-cell acute lymphoblastic leukemia, J Allergy Clin Immunol, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01571310

H. Ouadani, I. Ben-mustapha, M. Ben-ali, B. Largueche, T. Jovanic et al., Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate, Molecular Immunology, vol.79, pp.77-82, 2016.
DOI : 10.1016/j.molimm.2016.09.025
URL : https://hal.archives-ouvertes.fr/pasteur-01453058

K. Ben-farhat, I. Ben-mustapha, M. Ben-ali, K. Rouault, S. Hamami et al., A Founder Effect of c.257 + 2T > C Mutation in NCF2 Gene Underlies Severe Chronic Granulomatous Disease in Eleven Patients, Journal of Clinical Immunology, vol.66, issue.1, pp.547-54, 2016.
DOI : 10.1007/s00251-015-0878-6.
URL : https://hal.archives-ouvertes.fr/pasteur-01374995

N. Agrebi, S. Ben-mansour, L. Medhaffar, M. Hadiji, S. Fedhila et al., Autoimmune lymphoproliferative syndrome caused by homozygous FAS mutations with normal or residual protein expression, Journal of Allergy and Clinical Immunology, vol.140, issue.1, 2017.
DOI : 10.1016/j.jaci.2016.11.033
URL : https://hal.archives-ouvertes.fr/hal-01563901

I. Ben-mustapha, M. Ben-ali, N. Mekki, E. Patin, C. Harmant et al., A 1,100-year-old founder effect mutation in IL12B gene is responsible for Mendelian susceptibility to mycobacterial disease in Tunisian patients, Immunogenetics, vol.70, issue.3, pp.67-71, 2014.
DOI : 10.1016/S0065-2776(08)60387-9
URL : https://hal.archives-ouvertes.fr/pasteur-01061271

A. Sassi, S. Lazaroski, G. Wu, S. Haslam, M. Fliegauf et al., Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels, Journal of Allergy and Clinical Immunology, vol.133, issue.5, pp.1410-1419, 2014.
DOI : 10.1016/j.jaci.2014.02.025
URL : https://hal.archives-ouvertes.fr/pasteur-01060838

B. Halim, N. , B. A. Bouafif, N. Romdhane, L. et al., Consanguinity, endogamy, and genetic disorders in Tunisia, Journal of Community Genetics, vol.71, issue.2, pp.273-84, 2013.
DOI : 10.1111/j.1469-1809.2006.00308.x
URL : https://hal.archives-ouvertes.fr/pasteur-00859212

W. Anwar, M. Khyatti, and K. Hemminki, Consanguinity and genetic diseases in North Africa and immigrants to Europe, The European Journal of Public Health, vol.24, issue.suppl 1, pp.57-63, 2014.
DOI : 10.1093/eurpub/cku104

E. Harris, A. Weyrich, and G. Zimmerman, Lessons from rare maladies, Current Opinion in Hematology, vol.20, issue.1, pp.16-25, 2013.
DOI : 10.1097/MOH.0b013e32835a0091

I. Ben-mustapha, K. Ben-farhat, N. Guirat-dhouib, E. Dhemaied, B. Largueche et al., Clinical, Immunological and Genetic Findings of a Large Tunisian Series of Major Histocompatibility Complex Class II Deficiency Patients, Journal of Clinical Immunology, vol.1238, issue.12
DOI : 10.1111/j.1749-6632.2011.06260.x
URL : https://hal.archives-ouvertes.fr/pasteur-00860600

F. Mellouli, I. Mustapha, M. Khaled, H. Besbes, M. Ouederni et al., Report of the Tunisian Registry of Primary Immunodeficiencies: 25-Years of Experience (1988???2012), Journal of Clinical Immunology, vol.27, issue.1, pp.745-53, 2015.
DOI : 10.1007/s10875-006-9052-0
URL : https://hal.archives-ouvertes.fr/pasteur-01375025

M. Koker, Y. Camcioglu, K. Van-leeuwen, S. Kilic, I. Barlan et al., Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients, Journal of Allergy and Clinical Immunology, vol.132, issue.5, 2013.
DOI : 10.1016/j.jaci.2013.05.039

. Van-den, J. Berg, E. Van-koppen, A. Ahlin, B. Belohradsky et al., Chronic Granulomatous Disease: The European Experience, PLoS ONE, vol.8, issue.4, 2009.
DOI : 10.1371/journal.pone.0005234.t017
URL : https://hal.archives-ouvertes.fr/hal-00382226

W. Lee, T. Torgerson, M. Schumacher, L. Yel, Q. Zhu et al., Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome, Blood, vol.105, issue.5, pp.1881-90, 2005.
DOI : 10.1182/blood-2003-12-4420

O. Cabral-marques, S. Klaver, L. Schimke, E. Ascendino, T. Khan et al., First Report of the Hyper-IgM Syndrome Registry of the Latin American Society for Immunodeficiencies: Novel Mutations, Unique Infections, and Outcomes, Journal of Clinical Immunology, vol.82, issue.2, pp.146-56, 2014.
DOI : 10.1001/jama.2010.491

A. Freeman and S. Holland, Clinical Manifestations of Hyper IgE Syndromes, Disease Markers, vol.29, issue.3-4, pp.123-153, 2010.
DOI : 10.1155/2010/580197

C. Li, M. Rodriguez, and D. Banerjee, Cloning and characterization of complementary DNA encoding human N-acetylglucosamine-phosphate mutase protein, Gene, vol.242, issue.1-2
DOI : 10.1016/S0378-1119(99)00543-0

Y. Zhang, X. Yu, M. Ichikawa, J. Lyons, S. Datta et al., Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment, Journal of Allergy and Clinical Immunology, vol.133, issue.5, pp.1400-1409, 2014.
DOI : 10.1016/j.jaci.2014.02.013

A. Stray-pedersen, P. Backe, H. Sorte, L. Morkrid, N. Chokshi et al., PGM3 Mutations Cause a Congenital Disorder of Glycosylation with Severe Immunodeficiency and Skeletal Dysplasia, The American Journal of Human Genetics, vol.95, issue.1, pp.96-107, 2014.
DOI : 10.1016/j.ajhg.2014.05.007

H. Harms, K. Zimmer, K. Kurnik, R. Bertele-harms, S. Weidinger et al., Oral mannose therapy persistently corrects the severe clinical symptoms and biochemical abnormalities of phosphomannose isomerase deficiency, Acta Paediatrica, vol.213, issue.Suppl 1, pp.1065-72, 2002.
DOI : 10.1203/00006450-198002000-00117

M. Barbouche and B. Eley, Considerations for Primary Immune Deficiency Disorders in Africa and the Middle East, Stiehm's Immune Deficiencies, pp.957-64, 2014.
DOI : 10.1016/B978-0-12-405546-9.00054-6

G. Fisher, F. Rosenberg, S. Straus, J. Dale, L. Middleton et al., Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome, Cell, vol.81, issue.6, pp.935-981, 1995.
DOI : 10.1016/0092-8674(95)90013-6

C. Jackson, R. Fischer, A. Hsu, S. Anderson, Y. Choi et al., Autoimmune Lymphoproliferative Syndrome with Defective Fas: Genotype Influences Penetrance, The American Journal of Human Genetics, vol.64, issue.4, pp.1002-1016, 1999.
DOI : 10.1086/302333

H. Kuehn, I. Caminha, J. Niemela, V. Rao, J. Davis et al., FAS Haploinsufficiency Is a Common Disease Mechanism in the Human Autoimmune Lymphoproliferative Syndrome, The Journal of Immunology, vol.186, issue.10, pp.6035-6078, 2011.
DOI : 10.4049/jimmunol.1100021

A. Worth, A. Thrasher, and H. Gaspar, Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype, British Journal of Haematology, vol.172, issue.1, pp.124-164, 2006.
DOI : 10.1002/ana.410430120

B. Boisson, Y. Wang, A. Bosompem, C. Ma, A. Lim et al., A recurrent dominant negative E47 mutation causes agammaglobulinemia and BCR???????? B cells, Journal of Clinical Investigation, vol.123, issue.11, pp.4781-4786, 2013.
DOI : 10.1172/JCI71927DS1

R. Djidjik, N. Messaoudani, A. Tahiat, Y. Meddour, S. Chaib et al., Clinical, immunological and genetic features in eleven Algerian patients with major histocompatibility complex class II expression deficiency, Allergy, Asthma & Clinical Immunology, vol.8, issue.1, pp.14-24, 2012.
DOI : 10.1007/s00251-003-0609-2

L. Romdhane, R. Kefi, H. Azaiez, B. Halim, N. Dellagi et al., Founder mutations in Tunisia: implications for diagnosis in North Africa and Middle East, Orphanet Journal of Rare Diseases, vol.7, issue.1, pp.52-62, 2012.
DOI : 10.1186/1750-1172-7-52
URL : https://hal.archives-ouvertes.fr/pasteur-00859423

W. Al-herz, O. Alsmadi, M. Melhem, M. Recher, F. Frugoni et al., Major Histocompatibility Complex Class II Deficiency in Kuwait: Clinical Manifestations, Immunological Findings and Molecular Profile, Journal of Clinical Immunology, vol.134, issue.5, pp.513-522, 2013.
DOI : 10.1111/j.1365-2141.2006.06213.x

K. Clarridge, D. Leitenberg, B. Loechelt, C. Picard, and M. Keller, Major Histocompatibility Complex Class II Deficiency due to a Novel Mutation in RFXANK in a Child of Mexican Descent, Journal of Clinical Immunology, vol.134, issue.1, pp.4-5, 2016.
DOI : 10.1111/j.1365-2141.2006.06213.x

T. Prod-'homme, B. Dekel, G. Barbieri, B. Lisowska-grospierre, R. Katz et al., Splicing defect in RFXANK results in a moderate combined immunodeficiency and long-duration clinical course, Immunogenetics, vol.55, issue.8, pp.530-539, 2003.

B. Corneo, D. Moshous, T. Gungor, N. Wulffraat, P. Philippet et al., Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome, Blood, vol.97, issue.9, pp.2772-2778, 2001.
DOI : 10.1182/blood.V97.9.2772

J. De-villartay, A. Lim, H. Mousa, S. Dupont, J. Dechanet-merville et al., A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection, Journal of Clinical Investigation, vol.115, issue.11, pp.3291-3300, 2005.
DOI : 10.1172/JCI25178
URL : https://hal.archives-ouvertes.fr/hal-00020065

H. Ijspeert, G. Driessen, M. Moorhouse, N. Hartwig, B. Wolska-kusnierz et al., Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes, Journal of Allergy and Clinical Immunology, vol.133, issue.4, pp.1124-1157, 2014.
DOI : 10.1016/j.jaci.2013.11.028

L. Martinez-martinez, M. Vazquez-ortiz, C. Gonzalez-santesteban, A. Martin-nalda, A. Vicente et al., From Severe Combined Immunodeficiency to Omenn syndrome after hematopoietic stem cell transplantation in a RAG1 deficient family, Pediatric Allergy and Immunology, vol.2, issue.Suppl 1, pp.660-666, 2012.
DOI : 10.1159/000314077

F. Lanternier, S. Pathan, Q. Vincent, L. Liu, S. Cypowyj et al., Deep Dermatophytosis and Inherited CARD9 Deficiency, New England Journal of Medicine, vol.369, issue.18, pp.1704-1718, 2013.
DOI : 10.1056/NEJMoa1208487

L. Romdhane and S. Abdelhak, Research Unit on Molecular Investigation of Genetic Orphan Diseases, Collaborators. Genetic diseases in the Tunisian population, Am J Med Genet A, vol.1551, pp.238-67, 2011.